Strengthening Pakistan’s Diagnostic Infrastructure with AI-Enabled Imaging

Under the CPEC Phase-II framework, ShahCo Medical (Pvt.) Ltd. signed a landmark MoU with Neusoft Medical Systems in Beijing. This partnership marks a significant step in bringing high-end diagnostic solutions—including Advanced CT, MRI, and PET-CT systems—to Pakistan. By integrating AI-enabled diagnostics and specialized technical knowledge transfer, ShahCo is committed to upgrading the country’s imaging capabilities to meet international benchmarks.

Advancing Biotechnology and Next-Generation Oncology Care

ShahCo Medical has entered into a strategic cooperation with Bioocus Medical Group to introduce revolutionary biotechnology solutions to the Pakistani market. A key focus of this agreement is the deployment of CAR-T Cell Therapy and regenerative medicine. This collaboration ensures that Pakistani hospitals have access to the same life-saving innovations used in the world’s leading medical research centers.

Transforming Oncology through Cutting-Edge Co-Ablation Systems

During the Pakistan–China B2B Investment Conference, ShahCo Medical finalized an agreement with Hygea Medical Technology. This partnership focuses on introducing Co-Ablation technology—a minimally invasive alternative to traditional surgery—to oncology departments across Pakistan. Our role involves the full-scale supply, installation, and clinical training required to make advanced tumor ablation a standard of care nationwide.

A Breakthrough in Minimally Invasive Cancer Treatment

In a historic milestone for national healthcare, the Chief Minister of Punjab, Maryam Nawaz Sharif, inaugurated the country’s first Co-Ablation Center at Mayo Hospital. As the exclusive technology provider, ShahCo Medical successfully installed and commissioned this advanced system, which destroys tumors (Lung, Breast, Liver) in under 60 minutes. This installation represents our ability to deliver “impossible” solutions to the public sector, offering patients a safer, non-chemo alternative to surgery.

Leading the Dialogue on Advanced Hematology and CAR-T Therapy

Participating in the PBMT Group’s 2025 conference, ShahCo Medical showcased its commitment to Interventional Hematology. We highlighted our collaboration with Bioocus Medical Group, specifically focusing on the infrastructure required for CAR-T Cell Therapy. Our team engaged with top hematologists to discuss how ShahCo’s specialized equipment can support the next generation of blood and marrow transplant services.

Delivering High-End Diagnostic Solutions for Modern Radiology

At the 41st RSP Conference, ShahCo Medical demonstrated its comprehensive range of radiology solutions, from Weight-Bearing CT to High-Field MRI. As a company that started in radiology, we continue to lead the market by providing customized, high-uptime equipment that allows radiologists to provide more accurate diagnoses for complex cases.

Supporting the Evolution of Nuclear Medicine and Molecular Imaging

ShahCo Medical played a vital role in the 8th PSNM Conference, which focused on the “Generation Next” of nuclear medicine. Our team presented solutions for PET-CT and Cyclotron facilities, emphasizing our capability to handle the complex engineering and installation requirements of high-energy medical physics.

Exploring AI-Driven and Personalized Radiology on a Global Scale

Representing ShahCo Medical at the world’s largest radiology forum, our Director participated in RSNA 2025. By engaging with over 700 technical exhibitors, we vetted the latest advancements in AI-powered imaging and personalized care. This ensures that the solutions ShahCo brings to Pakistan are not just current, but future-proofed for the next decade of medical advancement.